Recent clinical evidence indicates that ACTH is indeed effective in inducing remission of nephrotic glomerular diseases like minimal change disease (MCD) and focal segmental glomerulosclerosis (FSGS) (Fernandez et al., 2001; Chakraborty et al., 2020), even those resistant to steroids. Here, POMC is linked to focal segmental glomerulosclerosis.